Renaissance Capital’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-49,916
Closed -$748K 71
2023
Q3
$748K Buy
49,916
+11,779
+31% +$199K 0.4% 51
2023
Q2
$719K Buy
38,137
+5,346
+16% +$85K 0.41% 51
2023
Q1
$587K Buy
+32,791
New +$548K 0.43% 55
2022
Q4
Sell
-37,337
Closed -$255K 92
2022
Q3
$255K Sell
37,337
-7,227
-16% -$120K 0.16% 77
2022
Q2
$873K Buy
44,564
+13,384
+43% +$280K 0.46% 49
2022
Q1
$675K Sell
31,180
-9,338
-23% -$198K 0.29% 69
2021
Q4
$954K Sell
40,518
-7,099
-15% -$170K 0.24% 70
2021
Q3
$1.25M Sell
47,617
-36,908
-44% -$893K 0.25% 67
2021
Q2
$2.05M Buy
84,525
+20,367
+32% +$501K 0.32% 53
2021
Q1
$1.6M Sell
64,158
-23,938
-27% -$633K 0.24% 55
2020
Q4
$2.42M Buy
+88,096
New +$2.36M 0.33% 41

Other funds holding SHC

Renaissance Capital's SHC Position: Q4 2023 in Review

Renaissance Capital sold out of Sotera Health (SHC) in Q4 2023, closing a stake of 49,916 shares — an estimated $748K sold.

Renaissance Capital first reported a position in SHC in Q4 2020 and held it in 11 quarters. The position peaked at $2.42M in Q4 2020. 179 funds tracked by Wall St. Rank hold SHC as of Q4 2023.

  • Renaissance Capital reported no remaining Sotera Health position as of Q4 2023 after selling out during the quarter.
  • Renaissance Capital sold 49,916 Sotera Health shares in Q4 2023, an estimated $748K.
  • Renaissance Capital first reported a position in Sotera Health in Q4 2020 and held it in 11 quarters.
  • Renaissance Capital's Sotera Health position peaked at $2.42M in Q4 2020.
  • 179 funds tracked by Wall St. Rank held Sotera Health as of Q4 2023.

Based on Renaissance Capital's 13F filing for Q4 2023, filed 5 Jan 2024.